Delivery technologies for genome editing

Yin, Hao, Kauffman, Kevin J., Anderson, Daniel G.·2017·Nature Reviews Drug Discovery

Cited by (597)

Items 401–500 of 597

  1. CRISPR-mediated gene editing for the surgeon scientist
    Stephen J. O’Brien, Matthew B. Ekman, Stephen E. Manek, Susan Galandiuk · 2019 · Surgery
  2. Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro
    Ina Guri, Yara Alrokh, Carina Graham, Ruhina Maeshima, Emanuel Rognoni, Matthew P. Caley, Łukasz Łaczmański, Stephen L. Hart, John Alexander McGrath, J. Jackow · 2024 · Journal of Investigative Dermatology
  3. CRISPR/Cas9 Technology: A Novel Approach to Obesity Research
    Zahra Khademi, Zahra Mahmoudi, Vasily N. Sukhorukov, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2024 · Current Pharmaceutical Design
  4. Applications of Gene Editing Technologies to Cellular Therapies
    Lindsay A. M. Rein, Haeyoon Yang, Nelson Jen An Chao · 2018 · Transplantation and Cellular Therapy
  5. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations
    Matthew R. Hart, Donovan J. Anderson, Christopher C. Porter, Tobias Neff, Michael G. Levin, Marshall S. Horwitz · 2018 · PLoS Genetics
  6. Multiplexed bioluminescence-mediated tracking of DNA double-strand break repairs in vitro and in vivo
    Jasper Che-Yung Chien, Christian E. Badr, Charles Pin‐Kuang Lai · 2021 · Nature Protocols
  7. Nucleic Acids as a Nature‐Inspired Scaffold for Macromolecular Prodrugs of Nucleoside Analogues
    Franziska Krüger, Vipin Kumar, Pere Monge, Carina Conzelmann, Nikaïa Smith, Kurt V. Gothelf, Martin Tolstrup, Jan Münch, Alexander N. Zelikin · 2019 · Advanced Science
  8. Nanotechnology and Nanomedicine
    Tahir Bashir Dar, Adil Bhat, Fleury Augustin Nsole Biteghe, Ab Raouf Bhat, Zaria Malindi · 2022 · Springer eBooks
  9. Risk assessment in gene therapy and somatic genome-editing: An expert interview study
    Merlin Bittlinger, Dirk Hoffmann, Anna Karolina Sierawska, Marcel Mertz, Axel Schambach, Daniel Strech · 2022 · Gene and Genome Editing
  10. New approaches and prospects of immunotherapy and gene therapy for prostate cancer
    Roshni Bibi, Koustav Sarkar · 2024 · Journal of Translational Genetics and Genomics
  11. The role of CRISPR-Cas9 and CRISPR interference technologies in the treatment of autoimmune diseases
    Zahra Khademi, Negar Mottaghi-Dastjerdi, Hamed Morad, Amirhossein Sahebkar · 2025 · Autoimmunity Reviews
  12. CRISPR Technology: Transforming the Future of Medicine and Diagnostics
    Kavita A. Iyer, Rumiana Tenchov, Leilani M. Lotti Diaz, Preeti Jain, Trupti Thite, Yi Deng, Qiongqiong Angela Zhou · 2025 · Biochemistry
  13. Bacterial Membrane Coating Potentiates Lipid Nanoparticles for mRNA Delivery
    Rui Wang, Lin Bao, Yiyan Yu, Runhe Zhang, Zhongyuan Guo, Luke J. Kubiatowicz, Nishta Krishnan, Ilkoo Noh, Edward Wang, Ronnie H. Fang et al. · 2025 · Nano Letters
  14. Screening of sinapic acid as a polyphenol stabilizing agent for enhanced miR-124 delivery in ulcerative colitis therapy
    Mingju Shui, Yi Chen, Miao Guo, Guofeng Zhong, Hongyi Li, Yaqin Xiao, Qin Yuan, Beixin Yuan, Xiaoying Liu, Hefeng Zhou et al. · 2025 · Journal of Controlled Release
  15. Advances in stem cell–derived beta-cell therapy: A new frontier in type 1 diabetes treatment
    Krishna S. Upadhye, Paritosh Tayade · 2026 · Cell Transplantation
  16. Current progress in CRISPR-Cas systems for rare diseases
    Juveriya Israr, Ajay Kumar · 2024 · Progress in molecular biology and translational science
  17. Photochemical RNA Editing of C to U by Using Ultrafast Reversible RNA Photo‐crosslinking in DNA/RNA Duplexes
    Shigetaka Nakamura, Kanako Ishino, Kenzo Fujimoto · 2020 · ChemBioChem
  18. Group I Intron-Based Therapeutics Through Trans-Splicing Reaction
    Chang Ho Lee, Seung Ryul Han, Seong‐Wook Lee · 2018 · Progress in molecular biology and translational science
  19. Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
    Emily A. Rex, Dahee Seo, Don B. Gammon · 2018 · Journal of Visualized Experiments
  20. Protein Delivery of Cell-Penetrating Zinc-Finger Activators Stimulates Latent HIV-1-Infected Cells
    Pedro R.L. Perdigão, Catarina Cunha-Santos, Carlos F. Barbas, Mariana Santa‐Marta, João Gonçalves · 2020 · Molecular Therapy — Methods & Clinical Development
  21. Photothermal Transfection for Effective Nonviral Genome Editing
    Nuri Oh, Sooyeon Park, Jin Woo Kim, Ji‐Ho Park · 2021 · ACS Applied Bio Materials
  22. Identification of a Rho-Dependent Termination Site In Vivo Using Synthetic Small RNA
    Xun Wang, Monford Paul Abishek N, Heung Jin Jeon, Jin He, Heon Man Lim · 2023 · Microbiology Spectrum
  23. Controlling Protein Expression by Delivery of RNA Therapeutics Using Lipid Nanoparticles
    Paulo J.C. Lin, Ying K. Tam · 2019 · Elsevier eBooks
  24. Guiding design and performance of nonviral nucleic acid delivery vehicles via machine learning
    John A. Hutchinson, Sidharth Panda, Plinio D. Rosales, Janey P Sowada, Miles S. Willis, Michael C. Leyden, Pródromos Daoutidis, Theresa M. Reineke · 2025 · Advanced Drug Delivery Reviews
  25. Direct cytosolic delivery of DNA by creating fast closable holes in the cell membrane
    Haili Wang, Wei You, Fan Gao, Lei Zhang, Aizong Shen, Fei Wang, Guang Chen, Xuan Nie, Lei Xia, Weiqiang Huang et al. · 2022 · Chemical Engineering Journal
  26. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment
    Ling-Wu Tong, Yong-Shan Hu, Shi-Jing Yu, Chenglei Li, Jingwei Shao · 2024 · Nanotechnology
  27. Development of an optimized protocol for generating knockout cancer cell lines using the CRISPR/Cas9 system, with emphasis on transient transfection
    Seyed Alireza Mousavi Kahaki, Nayereh Ebrahimzadeh, Hossein Fahimi, Arfa Moshiri · 2024 · PLoS ONE
  28. New technologies in gene therapy for inducing immune tolerance in hemophilia A
    Chiara Borsotti, Antonia Follenzi · 2018 · Expert Review of Clinical Immunology
  29. Prenatal Gene Therapy for Metabolic Disorders
    Barbara E. Coons, William H. Peranteau · 2021 · Clinical Obstetrics & Gynecology
  30. Governing nonconventional genetic experimentation
    Maxwell J. Mehlman, Ronald A. Conlon, Alex Pearlman · 2023 · Journal of Law and the Biosciences
  31. A universal strategy of facilitating intracellular delivery of nanomedicines based on tuning ARF6 GTPase to its GTP-bound form
    Siyang Song, Xiangfu Guo, Zibin Zhang, Shumin Fan, Runyu Zhang, Zhicheng Yan, Qing Chen, Yang Song, Peiyao Wu, Chunling Wang et al. · 2023 · Nano Today
  32. pH-responsive Drug Delivery Systems
    Zhaohui Wang, Xinyi Zhang, Gang Huang, Jinming Gao · 2018 · Royal Society of Chemistry eBooks
  33. Nuclear-Targeting Delivery of CRISPRa System for Upregulation ofβ-Defensin against Virus Infection by Dexamethasone and Phenylalanine Dual-Modified Dendrimer
    Mingxiang Zuo, Mingqiang Li, Shuang Liu, Bin Chen, Du Cheng · 2020 · Advances in Polymer Technology
  34. Personalized Therapeutics and Pharmacogenomics: Integral to Personalized Health Care
    Wolfgang Sadée · 2017 · Pharmaceutical Research
  35. Leveraging Endogenous ADAR for Programmable Editing on RNA
    Liang Qu, Zongyi Yi, Shiyou Zhu, Chunhui Wang, Zhongzheng Cao, Zhuo Long Zhou, Pengfei Yuan, Ying Fang Yu, Feng Tian, Zhiheng Liu et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  36. An immunostimulatory liponanogel reveals immune activation-enhanced drug delivery and therapeutic efficacy in cancer
    Xinyan Li, Chengcheng Wu, Junyao Li, Jinchao Yu, Xiuxiu Yang, Lvshan Yu, Chaoyu Wang, Rui Kuai · 2024 · Journal of Controlled Release
  37. Tools and delivery technologies for mitochondrial gene editing
    Nei Li, Bowen Wu, Yi Xiao, Yijia Hao, Fan Wu, Yinghui Wei, Ying Xu, Xuexiang Han · 2025 · Cell Biomaterials
  38. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients’ Induced Pluripotent Stem-Cell-Derived Cardiomyocytes
    Binyamin Eisen, Ofer Binah · 2023 · International Journal of Molecular Sciences
  39. Traditional Strategies and Cutting-Edge Technologies Used for Animal Breeding: A Comprehensive Review
    Ahmad Mohammad Khalil · 2025 · Sustainable Food Connect
  40. Nanotechnology-enhanced CRISPR systems for gene therapy – A review
    Mohammad Affan Kareem, Ashwini Aher, Sunil Namdev Thitame · 2025 · Multidisciplinary Reviews
  41. Vascular aging: implications, mechanisms, and interventions
    Sunny Chen, Jessica Lian, Ruth Mathew, Max Lu, Tommy Chen, Ali Imran Sarwar, Irena Levitan, Monica M. Lee, Jiwang Chen · 2024 · Aging Research
  42. Synthetic Biology Industry: Biosafety Risks to Workers
    Vladimir V. Murashov, John Howard, Paul A. Schulte · 2019 · Risk, systems and decisions
  43. Reshaping the Landscape of the Genome: Toolkits for Precise DNA Methylation Manipulation and Beyond
    Chenyou Zhu, Ziyang Hao, Dongsheng Liu · 2023 · JACS Au
  44. Mu transpososome activity-profiling yields hyperactive MuA variants for highly efficient genetic and genome engineering
    Tiina S. Rasila, Elsi Pulkkinen, Saija Kiljunen, Saija M. Haapa-Paananen, Maria I. Pajunen, Anu Salminen, Lars G. Paulin, Mauno Vihinen, Phoebe A. Rice, Harri Savilahti · 2017 · Nucleic Acids Research
  45. 65 YEARS OF THE DOUBLE HELIX: The advancements of gene editing and potential application to hereditary cancer
    Zi Ying Tan, Taosheng Huang, Joanne Yuen Yie Ngeow · 2018 · Endocrine Related Cancer
  46. Epigenetic regulation of Hutchinson-Gilford progeria syndrome: from molecular mechanisms to targeted interventions
    Xuan Liu, Shuhui Yang, Jiaxiao Jiang, Shasha Dong, Yu Zhang · 2025 · Oral Science and Homeostatic Medicine
  47. Nanotechnology-enhanced gene therapy for hearing loss
    Yiwen Liu, Lin Li, Pei Huang, Dingjun Zha, Hongzhang Deng · 2025 · Nanoscale Horizons
  48. De novo design of hypercompact transcript degraders by engineering substrate-specific toxins and Cas6-CBS system
    Pin-Ru Chen, Pei-Pei Qin, Yanan Wang, Pengfu Liu, Xin-Yue Zhang, Tao Qian, Bang‐Ce Ye, Bin‐Cheng Yin · 2025 · Nature Communications
  49. Suppression of HBV replication and expression by CRISPR/Cas9 ribonucleoproteins
    Addison C. Hill, Madison Schank, Yi Zhang, Ning Sun, Ling Wang, Juan Zhao, Puja Banik, Jaeden S. Pyburn, Holly K. Orfield, Janet Lightner et al. · 2025 · Antiviral Research
  50. A Nanoimprinted Photothermal Chip for On-Demand Spatiotemporal Activation of CRISPR/Cas9 Gene Editing
    Kerong Chen, Jiayi Zhu, Chunyun Fan, Anwei Zhou, Binyi Li, Haixiong Ge, Xinghai Ning · 2025 · Nano Letters
  51. Cationic Lipid Derived from a Basic Amino Acid: Design and Synthesis
    Diana M. Bravo‐Estupiñan, Mariela Montaño-Samaniego, Rodrigo Antonio Mora-Rodríguez, Miguel Ángel Ibáñez-Hernández · 2024 · Applied Sciences
  52. Genome editing in mouse spermatogonial stem cell lines targeting the Tex15 gene using CRISPR/Cas9
    Suheyla Yeşilbostan, Mustafa Yenal Akkurt, Sinan Özkavukçu, Oğuz Kul, Bengi Çınar Kul · 2025 · Frontiers in Veterinary Science
  53. Genome editing: development and regulatory challenges
    SC RPharm, Russia, 111B Leninsky prospect, 197002, Moscow, Russia, Samsonov MIu · 2017 · Cellular Therapy and Transplantation
  54. Non-viral Vectors for Gene Therapy
    Clévio Nóbrega, Liliana S. Mendonça, Carlos A. Matos · 2020 · Springer eBooks
  55. CRISPR/Cas9 Technology: Challenges and drawbacks
    Sibashish Baksi Ayan Ghorui · 2023 · Journal Of Advanced Zoology
  56. Electrochemical profiling of poliovirus particles inactivated by chemical method and ionizing radiation
    L.E. Agafonova, Victoria V. Shumyantseva, Yury Y. Ivin, Anastasia N. Piniaeva, Anastasia A. Kovpak, Aydar A. Ishmukhametov, Sergei V. Budnik, Roman S. Churyukin, Dmitry D. Zhdanov, A.I. Archakov · 2024 · Biomeditsinskaya Khimiya
  57. Nucleic acid delivery as a therapeutic approach for cancer immunotherapy
    Kashish Wilson, Garima, Meenakshi Dhanawat · 2024 · Advances in immunology
  58. Review on the bioanalysis of non-virus-based gene therapeutics
    Maotian Zhou, Xue Zhang, Huan Yan, Lili Xing, Tao Yi, Liang Shen · 2024 · Bioanalysis
  59. Investigational gene expression inhibitors for the treatment of idiopathic pulmonary fibrosis
    Paolo Spagnolo, Roberto Tonelli, Marco Mura, William Michael Reisman, Vasilina Sotiropoulou, Argyrios Tzouvelekis · 2025 · Expert Opinion on Investigational Drugs
  60. Binary Copolymer Blending Enhances pDNA Delivery Performance and Colloidal Shelf Stability of Quinine-Based Polyplexes
    Punarbasu Roy, Nicholas W. Kreofsky, Cristiam F. Santa Chalarca, Theresa M. Reineke · 2025 · Bioconjugate Chemistry
  61. Nanodelivery systems for gene editing drugs
    Yao Zhang, Yuan Ping · 2025 · Chinese Science Bulletin (Chinese Version)
  62. Evolutionary Timeline of Genetic Delivery and Gene Therapy
    Natalie J. Holl, Han‐Jung Lee, Yue‐Wern Huang · 2020 · Current Gene Therapy
  63. Nanomedicine enables efficient CRISPR-Cas9 genome editing for disease treatment
    Lifang Ma, Caihong Dong, Meihua Yu, Xinran Song, Yongchun Yu, Yu Chen · 2021 · 中国科学通报:英文版
  64. The theory and applications of CRISPR in plant and tree improvement.
    Jeremy D. Parsons, John J. MacKay · 2018 · CABI Reviews
  65. ACSNI: An unsupervised machine-learning tool for prediction of tissue-specific pathway components using gene expression profiles
    Chinedu Anthony Anene, Faraz Khan, Findlay Bewicke‐Copley, Eleni Maniati, Jun Wang · 2021 · Patterns
  66. Development of double strand RNA mPEI nanoparticles and application in treating invasive breast cancer
    Rui Liu, Li-Min Mu, Jing Bai, Ya-Fei Du, Ying Xie, Wan-Liang Lu · 2019 · RSC Advances
  67. [Development of CRISPR technology and its application in bone and cartilage tissue engineering].
    Guo Chen, Du Cheng, Bin Chen · 2019 · Europe PMC (PubMed Central)
  68. Delivery of biomacromolecules for therapeutic genome editing
    Ping Yuan, George McDonald Church · 2021 · Advanced Drug Delivery Reviews
  69. Comparative evaluation of liver-directed knockin strategies with viral and nonviral vectors in mouse inherited disease models
    Xiu Jin, Xiaoyi Wu, Junwei Song, Mei Luo, Qin Ye, Chengda Ren, Song Li, Manjun Li, Ming Hu, Yifan An et al. · 2025 · Molecular Therapy
  70. Ethical and Regulatory Considerations for Developing Gene Therapies Involving Genome Editing
    Pishoy Gouda, Lauren W. Cohen, Keith Berelowitz, Juli Murphy Bollinger, Julianne Bruno, Jeffrey E. Cehelsky, R. Alta Charo, Jamie Harrop, Jeffrey Kahn, Amy McGuire et al. · 2026 · Human Gene Therapy
  71. High-biocompatibility chitosan-based vectors for high-dose gene therapy in tumor suppression and wound healing
    Meiyu Shao, MengXin Niu, Qun Liu, Dandan Sui, Kai Zhang, Rui Lian, Yang Hu, Fu‐Jian Xu · 2026 · Biomaterials
  72. Engineering DNA-Targeting CRISPR and CRISPR-Like Effectors: Advances from Rational Design and High-Throughput Screening to AI-Driven Development
    Lingwei She, Zeyu Liang, Qin Zou, Yi‐Xin Huo · 2026 · ACS Synthetic Biology
  73. Multicellular systems to translate somatic cell genome editors to human
    Victor Hernandez‐Gordillo, Thomas Caleb Casolaro, Mo R. Ebrahimkhani, Samira Kiani · 2020 · Current Opinion in Biomedical Engineering
  74. Cancer Therapy with CRISPR/Cas9: Prospects and Challenges
    Muhammad Fahad Chaudhary, Unsa Saleem, Samia Khan, Rabiya Khan, Muhammad Asim, Fakhra Azam, Mariam Sharif, Zainab Zainab, Ali Abbas Dilawar, Muhammad Jehanzaib · 2021 · International Journal of Environment Agriculture and Biotechnology
  75. A CRISPR-Cas9-Based Therapeutics in Oxidative Stress-Induced Cancer
    Nivya Vijayan, V. P. Venkatiesh, Vani Vijay, Anbarasu Kannan, Baskaran Vallikannan, Madan Kumar Perumal · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
  76. Lipoplexes and Polyplexes for Targeted Gene Delivery
    Dimitriοs Selianitis, Martha Kafetzi, Νatassa Pippa, Stergios Pispas, Maria Gazouli · 2022 · Nanotechnology in the life sciences
  77. A Primer on Gene Editing: What Does It Mean for Pathologists?
    Allison M. Cushman‐Vokoun, Ryan J. Schmidt, Matthew Hiemenz, Mark K.Y. Fung, Bing Melody Zhang, Georganne Bradshaw, Manish J. Gandhi, JinJuan Yao, Sophia Louise Yohe, Amy K. Beckman et al. · 2023 · Archives of Pathology & Laboratory Medicine
  78. Women and Agricultural Entrepreneurship in Rural Areas in West Africa: Case of Benin
    Eyitayo Kegnide, Fifanou G. Vodouhê, Aklesso Y. G. Egbendéwé, Jacob Afouda Yabi · 2024 · American Journal of Agriculture and Forestry
  79. Chimeric DNA–RNA Guide RNA Designs
    Shuhan Lu, Ying Zhang, Hao Yin · 2020 · Methods in molecular biology
  80. Nonviral gene editing in cancer immunotherapy
    Yamin Li, Qiaobing Xu · 2021 · Elsevier eBooks
  81. CSH/SBE-β-CD nanoparticles: controlled synthesis and application for loading and pH-responsive drug release
    Chunrong Yi, Ying Li, Shuxin Zhang, Hai Fan, Ziqiang Cheng · 2022 · New Journal of Chemistry
  82. 3D Columnar Phase of Stacked Short DNA Organized by Coherent Membrane Undulations
    Nathan F. Bouxsein, Cecília Leal, Christopher S. McAllister, Youli Li, Kai K. Ewert, Charles E. Samuel, Cyrus R. Safinya · 2019 · Langmuir
  83. CRISPR Toolbox for Mammalian Cell Engineering
    Daria Sergeeva, Karen Julie la Cour Karottki, Jae Seong Lee, Helene Faustrup Kildegaard · 2019 · Wiley eBooks
  84. IL-23 inhibitor enhances the effects of PTEN DNA-loaded lipid nanoparticles for metastatic CRPC therapy
    Xinlu Chen, Luyao Gong, Yuanyuan Wang, Chen Ye, Huanhuan Guo, Shen Gao, Jiyuan Chen, Zhuo Wang, Yuan Gao · 2024 · Frontiers in Pharmacology
  85. Designer Babies are No Longer Science Fiction: What are The Ethical Considerations?
    Urfa Khairatun Hisan, Cyril B. Romero · 2023 · Bincang Sains dan Teknologi
  86. Expression and purification of cell-penetrating Cas9 and Cas12a enzymes for peptide-assisted genome editing
    Rosella G Cuomo, Zhen Zhang, Keisuke YAMADA, Alexander J Krosky, Junwei Shi, Rahul M. Kohli, Jared B. Parker · 2024 · Methods in enzymology on CD-ROM/Methods in enzymology
  87. Development and application of epigenome editors
    Yangyang Sun, Hanhui Ma · 2025 · Scientia Sinica Vitae
  88. Sílices mesoporosas: del mundo inorgánico a la entrega de fármacos
    Mariana Giselle Flores Cruz, Luz Maria Lopez-Marin · 2025 · Mundo Nano Revista Interdisciplinaria en Nanociencia y Nanotecnología
  89. Recent advances in gene therapy for neurological disorders: A comprehensive overview
    Diksha Jindal · 2025 · Adesh University Journal of Medical Sciences & Research
  90. Electroporation-based CRISPR/Cas9 Gene Editing in Haliotis Discus Hannai
    Chen Liu, Dianzhi Yao, Yulu Jiang, Chuncao Huo, Jinhai Zhang, Suyuan Yi, Wenhao Yang, Yijing Han, Yaqiong Liu, Xiaotong Wang · 2025 · Marine Biotechnology
  91. Decoding RNA therapeutics: Precision approaches in women's health
    Nazanin Pazhouhesh Far, Hoda Nouri Boroujerdi, Mahshid Seyed Karimi, Payam Vezvaei, Mahsa Behfar, Roya Mirzaei, Reza Habibi, Mahsa Manafi Varkiani, Amir Reza Aref, Nasim Ebrahimi · 2025 · European Journal of Pharmacology
  92. CRISPR/Cas9-integrated nanocarriers for cancer gene therapy: Mechanistic insights, challenges, and clinical translation
    Abhay Thakur, Rahul Sharma, Rohit Sharma, Kamal Jeet, Amar Deepak · 2025 · Journal of Drug Delivery Science and Technology
  93. Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels
    Shifeng Zhao, Shiyun Huang, Nan Li, Neng Wang, Zhitao Yu, Xiaoyu Liang, Zhenhuang Yang, Hongchang Guo · 2026 · ACS Applied Bio Materials
  94. Harnessing CRISPR-Cas technology for insect pest control: current advances and future perspectives
    Nareshkumar Arjunan, V. Thiruvengadam · 2026 · Molecular Biology Reports
  95. TRIM27-Cas9–loaded EVs suppress HCC proliferation and enhance responsiveness to anti–PD-1 therapy by promoting ACSL4-mediated ferroptosis
    Jie Wen, Zhihui Wang, Zhirui Zeng, Yu Tian, H Liu, Xiaokai Zhang, Shaoqing Niu, Milad Ashrafizadeh, Gautam Sethi, Wenpeng Cao et al. · 2026 · Cell Death and Differentiation
  96. Dense RNA motif modifications enable robust in vivo prime editing and enhance efficiencies of diverse editing systems
    Xinlin Lei, Didi Chen, Kun Zhang, Xiyu Liu, Qiubing Chen, Yizhou Zhang, Ruijin Ji, Jicheng Zhu, Qingyi Zhang, Ying Zhang et al. · 2026 · Nature Biomedical Engineering
  97. CRISPR Highlights and Transition of Cas9 into a Genome Editing Tool
    Thomas Bentin · 2018 · Royal Society of Chemistry eBooks
  98. Targeted Therapeutic Genome Engineering: Opportunities and Bottlenecks in Medical Translation
    Jessica A. Kretzmann, David C. Luther, Marck Nörret, Vincent M. Rotello, K. Swaminathan Iyer · 2019 · ACS symposium series
  99. Improvement of Rice Quality via Biofortification of Micronutrients
    Mohammad Hasanzadeh, Nahid Hazratı · 2020 · Springer eBooks
  100. A CRISPR-Cas9-Based Therapeutics in Oxidative Stress-Induced Cancer
    Nivya Vijayan, V. P. Venkatiesh, Vani Vijay, Anbarasu Kannan, Baskaran Vallikannan, Madan Kumar Perumal · 2022 · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects